Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  medroxyprogesterone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 48 for your search:
Start Over
Phase III Chemohormonal Therapy with ADR/CCNU/VCR/FXM vs CTX/MPA plus Immunotherapy with C. parvum for Metastatic Renal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 70
Sponsor:
Protocol IDs: MSHMC-REN-2
CACP/HMM vs CACP/HMM/MPA for Advanced Epithelial Ovarian Tumor - A Phase III Study
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-019-073, BUCRC-751
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069015, E-2193, NCI-P01-0194, ECOG-E2193, NCT00026286
Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069217, NCCTG-N99C7, NCI-P02-0204, NCT00030914
Phase III Provera (MPA) vs ADR vs ADR/CTX for Stage III/IV or Recurrent Endometrial Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-48, GOG-7941
Phase III Postinfarction Nephrectomy plus Medroxyprogesterone Acetate for Metastatic Renal Cell Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7956
Phase III Comparison of Immuneron vs Depo-Provera in Patients with Metastatic Renal Cell Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: BGSM-89285, NCI-V85-0243
Phase III Evaluation of High-dose vs Low-dose Medroxyprogesterone Acetate for Advanced Stage III/IV Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-10802
Phase III Randomized Study of Hormonal Therapy with TMX vs High-Dose MPA in Adult Patients with Advanced Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: POA-74185
Phase III Randomized Trial of IFN-A vs MPA in Patients with Metastatic Renal Carcinoma (Summary Last Modified 07/98)
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-RE01, EU-91021
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000468571, LEONB-PERCY-QUATTRO, EU-20605, LEONB-ET99-058, ROCHE-LEONB-PERCY-QUATTRO, CHIRON-LEONB-PERCY-QUATTRO, NCT00416429
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065314, CALGB-49901, S9630, U10CA037429, U10CA032102, SWOG-S9630, SWOG-9630, NCT00002920
Phase II Chemotherapy with VBL/CCNU/HU and Hormone Therapy with Medroxyprogesterone Acetate for Metastatic Renal Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-P33
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Phase: Phase II
Type: Prevention
Status: Completed
Age: 25 to 50
Sponsor: NCI
Protocol IDs: NCI-2013-00466, ID01-340, CDR0000069277, NCI-P02-0218, MDA-ID-01340, N01CN05127, TX035, NCT00033358
Phase II Hormone Therapy with MPA for Metastatic or Recurrent Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8111
Start Over